Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 7-11, 15 July 2004

Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis

  • Takeshi Oki

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-43-222-7171x5414; fax: +81-43-226-2160.
    • Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan
  • ,
  • Shunji Takahashi

      Affiliations

    • Environmental Biochemistry, Chiba University School of Medicine, Chiba, Japan
  • ,
  • Satoshi Kuwabara

      Affiliations

    • Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan
  • ,
  • Yasumasa Yoshiyama

      Affiliations

    • Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan
  • ,
  • Masahiro Mori

      Affiliations

    • Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan
  • ,
  • Takamichi Hattori

      Affiliations

    • Department of Neurology, Chiba University School of Medicine, 1-8-1 Inohana, Chuo, Chiba 260-8670, Japan
  • ,
  • Nobuo Suzuki

      Affiliations

    • Environmental Biochemistry, Chiba University School of Medicine, Chiba, Japan

Received 23 April 2003; received in revised form 5 February 2004; accepted 16 March 2004.

Abstract 

T lymphocytes and macrophages probably play a role in the pathogenesis of multiple sclerosis (MS), and migration of these cells into the central nervous system is facilitated by disruption of the capillary basement membrane. Laminin is a major extracellular matrix of the basement membrane. To investigate whether ability of lymphocytes to degrade laminin correlates with disease activity in MS, we conducted a prospective study in consecutive 24 MS patients. A novel quantitative assay was developed to estimate the ability of peripheral blood mononuclear cells (PBMCs) to degrade laminin. The assay was performed every four weeks over a period of 12 months. During the study period, a total of 41 relapses were observed. The ability to degrade laminin was significantly higher in MS patients, even during clinical remission, than in normal and neurological controls, and was transiently increased further within 4 weeks before relapse (p=0.076). In MS, the ability of peripheral blood lymphocytes to degrade laminin increases, and may correlate with disease activity.

Keywords:  Multiple sclerosis, Laminin, Blood–brain barrier, Lymphocyte

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-510X(04)00094-2

doi:10.1016/j.jns.2004.03.026

Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 7-11, 15 July 2004